z-logo
open-access-imgOpen Access
Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study
Author(s) -
Vivencio Barrios,
Carlos Escobar,
Alberto Calderón,
Rocío Echarri,
Sara Barrios,
Josefa NavarroCid
Publication year - 2009
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320309343596
Subject(s) - candesartan , medicine , left ventricular hypertrophy , diabetes mellitus , cardiology , blood pressure , regimen , ejection fraction , muscle hypertrophy , angiotensin ii , heart failure , endocrinology
This study examined the influence of diabetes on left ventricular hypertrophy (LVH) detected by different electrocardiographic (ECG) criteria and its changes induced by a 12-month candesartan-based regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom